Unusual Machines, Inc.
UMAC NYSE Radio & Tv Broadcasting & Communications Equipment Financials FY2022βFY2025
What Unusual Machines, Inc. does
No business description yet.
- Legal name
- Unusual Machines, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 12, 2026
- Accession Β· CIK
- 0001683168-26-001730
0001956955
Revenue and margins
Unusual Machines, Inc. had $11.2M of revenue in fiscal 2025, up 101.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$23.2M in fiscal 2025, β207.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Unusual Machines, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 212.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Unusual Machines, Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $3.1M | $0.9M | $3.8M | $142M |
| Interest coverage | β | β | β145.2x | β |
| Current ratio | 23.8x | 8.9x | 6.5x | 29.3x |
| Quick ratio | 23.8x | 8.9x | 5.1x | 28.3x |
| Total assets | $3.3M | $1.5M | $16.1M | $183M |
| Total liabilities | $0.1M | $0.1M | $1.3M | $7.8M |
| Shareholders' equity | $3.2M | $1.4M | $14.8M | $175M |
| Net debt (β = net cash) | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | 2 / 7 | 2 / 7 | 3 / 8 |
| Accruals ratio | 0.5% | β25.0% | β317.3% | 2.0% |
| Altman Z'' | 27.50 | β2.02 | β0.19 | 27.27 |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $0.0M | $0.0M | $5.6M | $11.2M |
| Gross profit | $0.0M | $0.0M | $1.5M | $3.9M |
| Research and development | $0.1M | $0.0M | $0.1M | $0.2M |
| Operating income | β$1.2M | β$2.4M | β$17.0M | β$25.2M |
| Interest expense | β | $0.0M | $0.1M | $0.0M |
| Pretax income | β$1.2M | β$2.4M | β$32.0M | β$19.2M |
| Income tax | $0.0M | $0.0M | β$0.0M | β$0.0M |
| Net income | β$1.2M | β$2.4M | β$32.0M | β$19.2M |
| Diluted EPS | β$0.29 | β$0.72 | β$3.84 | β$0.74 |
| Diluted shares | 0.00B | 0.00B | 0.01B | 0.03B |
| Cash flow | ||||
| Cash from operations | β$1.2M | β$1.8M | β$4.0M | β$21.2M |
| Capital expenditure | $0.0M | $0.0M | $0.0M | $2.1M |
| Free cash flow | β$1.2M | β$1.8M | β$4.0M | β$23.2M |
| Depreciation and amortization | $0.0M | $0.0M | $0.1M | $0.1M |
| Stock-based compensation | $0.0M | $0.6M | $2.3M | $15.6M |
| Acquisitions | β | $0.0M | $0.9M | β$0.1M |
| Balance sheet | ||||
| Cash and short-term investments | $3.1M | $0.9M | $3.8M | $142M |
| Current assets | $3.1M | $1.0M | $6.1M | $160M |
| Current liabilities | $0.1M | $0.1M | $0.9M | $5.4M |
| Inventory | β | $0.0M | $1.3M | $5.3M |
| Property and equipment, net | $0.0M | $0.0M | $0.0M | $2.2M |
| Goodwill | β | $0.0M | $7.4M | $15.6M |
| Intangible assets | β | $0.0M | $2.2M | $2.6M |
| Total assets | $3.3M | $1.5M | $16.1M | $183M |
| Total liabilities | $0.1M | $0.1M | $1.3M | $7.8M |
| Preferred stock | $0.0M | $0.0M | β | β |
| Shareholders' equity | $3.2M | $1.4M | $14.8M | $175M |
| Margins | ||||
| Gross margin | β | β | 27.8% | 34.9% |
| Operating margin | β | β | β305.3% | β224.6% |
| EBITDA margin | β | β | β304.0% | β223.3% |
| Net margin | β | β | β574.6% | β171.4% |
| FCF margin | β | β | β71.8% | β207.5% |
| Returns | ||||
| Return on capital employed | β36.6% | β168.5% | β112.0% | β14.2% |
| Return on equity | β36.6% | β103.3% | β394.0% | β20.2% |
| Return on assets | β35.2% | β98.1% | β362.7% | β19.3% |
| Return on tangible equity | β36.6% | β168.5% | β616.3% | β12.2% |
| Growth | ||||
| Revenue growth | β | β | β | 101.2% |
| Share count change | β | β18.4% | 151.7% | 212.5% |
| Financial health | ||||
| Interest coverage | β | β | β145.2x | β |
| Current ratio | 23.8x | 8.9x | 6.5x | 29.3x |
| Quick ratio | 23.8x | 8.9x | 5.1x | 28.3x |
| Capital allocation | ||||
| Capex / revenue | β | β | 0.0% | 18.4% |
| Stock comp / revenue | β | β | 40.5% | 139.5% |
| Quality scores | ||||
| Piotroski F-score | β | 2.0 | 2.0 | 3.0 |
| Altman Z'' | 27.5 | β2.0 | β0.2 | 27.3 |
| Accruals ratio | 0.5% | β25.0% | β317.3% | 2.0% |
Source: SEC EDGAR XBRL filings (CIK 0001956955). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.